SAHPRA cautions against fake Ozempic and alternatives

Loading player...
GUEST - Deon Poovan, he is the Acting Chief Regulatory Officer at SAHPRA.

The South African Health Products Regulatory Authority (SAHPRA) said it is concerned about the increased sales of weight loss products made available to the public via websites, social media platforms and other informal channels.

According to SAPHRA, these products pose a serious health risk to the public. The authority has thus cautioned citizens not to purchase and/or consume such products as their safety, efficacy and quality have not been assessed.
13 Nov 2024 5PM English South Africa Business News · Investing

Other recent episodes

BofA Slashes SA Growth Forecast as Inflation Surges

Bank of America has cut South Africa’s 2026 GDP growth forecast to 1.3%, warning that higher oil and fertilizer prices will keep inflation above 4% for most of the year. Economist Tatonga Rusike explains
23 Apr 3PM 11 min

Understanding SA’s First Wealth Score

Franc unveils South Africa’s first-ever Wealth Score, revealing that financial habits—not income—are the strongest predictor of financial health. We unpack why SA’s national score is 45/100 and the behavior gap between knowing and doing with Dr. Thomas Brennan, founder and CEO of Franc.
23 Apr 3PM 13 min

Clicks Lifts HEPS 8% Despite Warehouse Disruptions.

Clicks delivered firm interim results with diluted HEPS up 8.1%, even as warehouse system delays cost an estimated R175 million in lost sales. CEO Bertina Engelbrecht discusses pharmacy growth, trading margins, and festive‑season competition.
23 Apr 2PM 16 min